Parkinson’s disease, also known as “tremor palsy”, is a common neurodegenerative disease of the elderly. Parkinson’s disease is a chronic and progressive disease characterized by resting tremor, rigidity, bradykinesia and abnormal posture and gait. As the disease progresses, patients will gradually lose the ability to take care of themselves, and eventually develop movement disorders and can only lie rigidly in bed, and will eventually die of various complications, such as pneumonia and malnutrition. Treatments for Parkinson’s disease include medications, stereotactic disfigurement, and deep brain electrical stimulation (pacemaker). Brain pacemaker is the biggest breakthrough in the treatment of Parkinson’s disease. It is based on the principle of implanting a brain pacemaker into the body using a stereotactic method, which delivers weak electrical impulses to stimulate the relevant nerve nuclei in the brain that control movement, inhibiting the abnormal nerve signals that cause the symptoms of Parkinson’s Disease, eliminating the symptoms of Parkinson’s Disease, and restoring the patient’s ability to move freely and take care of him/herself. Brain pacemaker treatment for Parkinson’s disease is sure, safe and long-lasting. Compared with stereotactic disfiguration, its biggest advantage is non-destructive and reversible, avoiding irreversible and serious complications caused by the destruction of neuronal nuclei, and since it does not destroy the brain tissue, it also preserves the opportunity for the patient to receive other new treatments in the future.